SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-223706
Filing Date
2018-07-23
Accepted
2018-07-23 16:10:58
Documents
6
Period of Report
2018-07-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d555279d8k.htm 8-K 18764
2 EX-1.1 d555279dex11.htm EX-1.1 164638
3 EX-5.1 d555279dex51.htm EX-5.1 8640
4 EX-99.1 d555279dex991.htm EX-99.1 10699
5 EX-99.2 d555279dex992.htm EX-99.2 9678
6 GRAPHIC g555279g0723115720197.jpg GRAPHIC 2238
  Complete submission text file 0001193125-18-223706.txt   216887
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36279 | Film No.: 18964597
SIC: 2834 Pharmaceutical Preparations